Fellowship · Ann Arbor, MI
Sponsored by University of Michigan
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary.
The European respiratory journal · 2023 · 1,068 citations · MeiLan Han
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary.
American journal of respiratory and critical care medicine · 2023 · 597 citations · MeiLan Han
Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission.
Lancet (London, England) · 2022 · 560 citations · MeiLan Han
Definition and Nomenclature of Chronic Obstructive Pulmonary Disease: Time for Its Revision.
American journal of respiratory and critical care medicine · 2022 · 416 citations · MeiLan Han
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype.
The New England journal of medicine · 2025 · 112 citations · MeiLan Han
Airway-Occluding Mucus Plugs and Mortality in Patients With Chronic Obstructive Pulmonary Disease.
JAMA · 2023 · 180 citations · MeiLan Han
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial.
The Lancet. Respiratory medicine · 2025 · 72 citations · MeiLan Han
Management of Stage III Non-Small-Cell Lung Cancer: ASCO Guideline.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022 · 266 citations · Douglas Arenberg